Regeneron Pharmaceutical (NASDAQ: REGN)
| Last Price | $526.53 |
| Net Change | $4.51 (0.86%) |
| Bid | $456.55 |
| Ask Price | $0 |
| Open Price | $525 |
| Previous Close Price | $522.02 |
| High Price | $543.55 |
| Low Price | $521.5 |
| Number of Trades | 9,865 |
| Volume | 1,843,500 |
| Fifty Two Week High | $543.55 (2017-06-22) |
| Fifty Two Week Low | $325.35 (2016-11-04) |
| Average Daily Volume | 979,127 |
| Share Outstanding | 106,290 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $2.92 (2017-05-04) |
| 2nd Quarter Earnings | $3.04 (2017-02-09) |
| 3nd Quarter Earnings | $3.13 (2016-11-04) |
| 4th Quarter Earnings | $2.82 (2016-08-04) |
| PE Ratio | $58.85 |
| EPS Growth | $27.36 |
| Recent Earnings | $2.92 |
| Annual EPS | $8.87 |
| Last Quarter EPS | $ |
| Market Capitalization | $55.96B |
| Insider Shareholders % | 0.104% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 106,290 |
| Inst. Shareholder % | 67.23% |
| Annual Net Income | $0.96B |
| TTM Net Profit Margin | $19.66 |
| 1-Year Return | 47.43% |
| 3-Year Return | 89.32% |
| 5-Year Return | 362.07% |
| 5-Year Revenue Growth | 990.22% |
| 5-Year Earnings Growth | -442.74% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | 27.360001% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 1.53 |
REGN News & Stock Updates
June 21, 2017
Dow Jones News Today: Oil Prices Fall to 10-Month Low as OPEC Mulls an Increase in Production CutsApril 26, 2017
If You Own Just One Pharma Stock, Make It ThisFebruary 27, 2017
These Numbers Prove Big Pharma Is Scared of TrumpNovember 4, 2016
Dow Jones Industrial Average Slides After October Jobs ReportMay 12, 2015
Two Divergent Northbound Stocks to Buy Right Now